MA moves to revoke license of pharmacy linked to meningitis outbreak
Inspectors have finished the first stage of an investigation at the compounding pharmacy that produced the steroids linked to the fungal meningitis outbreak, New England Compounding Center in Framingham. The inspection paints a picture of a pharmacy poised for problems. One claim is that batches of the steroid linked to deaths across the country were shipped out before NECC pharmacists had even confirmed they were safe.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- PCI: Concerns Mount About Appropriateness
- MA an Insurance Proving Ground for Providers
- Transforming Cancer Care
- Targeting Self-Insured Populations